Ignite Creation Date:
2024-05-05 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00157248
Status:
TERMINATED
Last Update Posted:
2014-05-19
First Post:
2005-09-08
Brief Title:
Long-term Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Study Overview
Official Title:
Long-term Open-label Follow-up Treatment of Patients With Atrial Fibrillation Who Have Been Previously Treated With BIBR 1048 in the PETRO Trial Trial 116020 - NCT01227629 PETRO Extension Trial PETRO-Ex
Status:
TERMINATED
Status Verified Date:
2014-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine the long term safety and efficacy of BIBR 1048 in patients with chronic atrial fibrilla tion with or without concomitant chronic treatment with acetylsalicylic acid ASA
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None